NIPH Clinical Trials Search

Basic Information

Recruitment status	completed
Health condition(s) or Problem(s) studied
Date of first enrollment	13/04/2020
Target sample size	400
Countries of recruitment	Japan,North America,South America,Europe,null
Study type	Interventional
Intervention(s)	investigational material(s) Generic name etc : INN of investigational material : sarilumab Therapeutic category code : 399 Agents affecting metabolism, n.e.c. Dosage and Administration for Investigational material : control material(s) Generic name etc : INN of investigational material : - Therapeutic category code : --- Other Dosage and Administration for Investigational material :

Outcome(s)

Primary Outcome	efficacy
Secondary Outcome	efficacy efficacy efficacy efficacy efficacy efficacy efficacy efficacy efficacy efficacy efficacy efficacy efficacy efficacy efficacy efficacy efficacy efficacy efficacy efficacy safety safety safety safety safety

Key inclusion & exclusion criteria

Age minimum	>= 18age old
Age maximum	Not applicable
Gender	Both
Include criteria
Exclude criteria